Alan W.Partin M.D., Ph.D., Professor of Urology the Johns Hopkins Medical Institution, has
both basic science and clinical interest in prognosis prediction for men with prostate cancer. Dr. Partin's
laboratories and clinical and surgical interest are focused on development and testing of new and existing methods
for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients
and physicians. Dr. Partin's laboratories have investigated many new serum tests, some of which are soon to become available
for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection,
and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in treatment of benign prostatic
hyperplasia with an emphasis on minimally invasive techniques for treatment of this common disease of men.